Gerhard Glatting’s research focuses on optimizing individualized diagnosis and therapy, with particular emphasis on translating theoretical and computational methods into clinical practice.
His main research areas include:
- Optimization of molecular radiotherapy through the integration of prior knowledge from individual imaging, patient population data, and general (patho)physiological and radiobiological principles.
- Development and clinical translation of physiologically based pharmacokinetic (PBPK) and nonlinear mixed-effects (NLMEM) models for individualized dosimetry and therapy optimization.
- In silico studies to improve therapy planning in molecular radiotherapy.